Disclosure of payments made to HCPs and HCOs in the UK
Cooperation between pharmaceutical companies, regulators, Healthcare Professionals (HCPs), Healthcare Organisations (HCOs) and patients, is essential for the sustainable improvement of healthcare. These relationships have helped deliver numerous innovative new medicines and changed the way many diseases impact on our lives. HCPs have always been and will always remain valuable partners for GSK.
Our payments to HCPs and HCOs
Our transfers of value to individual healthcare professionals and healthcare organisations from 2015, have been submitted to the ABPI disclosure database. To access the data and for further information about our approach to implementing the ABPI Code of Practice regarding disclosure, please see the UK disclosures page on gsk.com. Annual data will be available for three years from its published date.
Date of preparation: January 2019, UK/COM/0035/15e(5).